CIK 0001933414 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Mineralys Therapeutics, Inc.
Sign in to watch- Ticker
- MLYS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 841966887
- Phone
- (888) 378-6240
- Business address
- 150 N. RADNOR CHESTER ROAD, SUITE F200, RADNOR, PA
- 4 Open-market buy Director bought 600,000 shares at $13.50 ($8,100,000)
- 4 Open-market buy Director bought 1,296,296 shares at $13.50 ($17,499,996)
- 4 Option exercise Chief Medical Officer acquired 6,349 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Option exercise Chief Medical Officer acquired 6,348 shares (option exercise)
- 4 Planned sale CFO and Secretary sold 10,757 shares at an average $9.10 ($97,864)
- 4 Option exercise Chief Medical Officer acquired 11,367 shares (option exercise)
- 4 Planned sale Chief Executive Officer sold 18,333 shares at $9.06 ($166,082)
- 4 Derivatives Options or other derivatives
- 4 Option exercise Chief Medical Officer acquired 5,017 shares (option exercise)
- 4 Planned sale Chief Medical Officer sold 5,026 shares at $15.00 ($75,398)
Page 5 of 9 · 180 filings